| Dr Todd A Bickmore, MD | |
|
385 W Main St, Avon, CT 06001-4357 | |
| (860) 777-1280 | |
| (860) 777-1276 |
| Full Name | Dr Todd A Bickmore |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 15 Years |
| Location | 385 W Main St, Avon, Connecticut |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1952315632 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Hartford Hospital | Hartford, CT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Hartford Healthcare Urgent Care Centers Llc | 7618242777 | 134 |
| South-west Community Health Center Inc | 2466445200 | 45 |
News Archive
Sorrento Therapeutics, Inc. and IGDRASOL announced today that IGDRASOL will be presenting updates of its analysis of proprietary late clinical stage NBN-Pac formulations, namely IG-001 (Cynviloq) and IG-004 (a D-a-tocopheryl polyethylene glycol succinate (TPGS)-based paclitaxel formulation) at the annual Nanomedicine 2013 meeting in Barcelona, Spain (April 11th - 12th).
The COVID-19 pandemic has thrown up unimaginable challenges for healthcare workers. Even simple outpatient procedures such as endoscopies can expose staff to the risk of infection.
Today, the U.S. Food and Drug Administration announced a final rule for the unique device identification system that, once implemented, will provide a consistent way to identify medical devices.
Biochemists at the University of California San Diego have uncovered patterns in the outer protein coat of group A Streptococcus that could finally lead to a vaccine against this highly infectious bacteria-responsible for more than 500,000 deaths a year, including toxic shock syndrome and necrotizing fasciitis or "flesh-eating disease."
At the heart of brain diseases such as amyotrophic lateral sclerosis, Alzheimer's disease, and Parkinson's disease is protein misfolding, in which distorted proteins are unable to perform their normal functions. At present, there is no known way to reverse protein misfolding.
› Verified 8 days ago
| Entity Name | South-west Community Health Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1699703686 PECOS PAC ID: 2466445200 Enrollment ID: O20040420001098 |
News Archive
Sorrento Therapeutics, Inc. and IGDRASOL announced today that IGDRASOL will be presenting updates of its analysis of proprietary late clinical stage NBN-Pac formulations, namely IG-001 (Cynviloq) and IG-004 (a D-a-tocopheryl polyethylene glycol succinate (TPGS)-based paclitaxel formulation) at the annual Nanomedicine 2013 meeting in Barcelona, Spain (April 11th - 12th).
The COVID-19 pandemic has thrown up unimaginable challenges for healthcare workers. Even simple outpatient procedures such as endoscopies can expose staff to the risk of infection.
Today, the U.S. Food and Drug Administration announced a final rule for the unique device identification system that, once implemented, will provide a consistent way to identify medical devices.
Biochemists at the University of California San Diego have uncovered patterns in the outer protein coat of group A Streptococcus that could finally lead to a vaccine against this highly infectious bacteria-responsible for more than 500,000 deaths a year, including toxic shock syndrome and necrotizing fasciitis or "flesh-eating disease."
At the heart of brain diseases such as amyotrophic lateral sclerosis, Alzheimer's disease, and Parkinson's disease is protein misfolding, in which distorted proteins are unable to perform their normal functions. At present, there is no known way to reverse protein misfolding.
› Verified 8 days ago
| Entity Name | Hospitalist Medicine Physicians Of Connecticut Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1558696153 PECOS PAC ID: 8628104072 Enrollment ID: O20100325000168 |
News Archive
Sorrento Therapeutics, Inc. and IGDRASOL announced today that IGDRASOL will be presenting updates of its analysis of proprietary late clinical stage NBN-Pac formulations, namely IG-001 (Cynviloq) and IG-004 (a D-a-tocopheryl polyethylene glycol succinate (TPGS)-based paclitaxel formulation) at the annual Nanomedicine 2013 meeting in Barcelona, Spain (April 11th - 12th).
The COVID-19 pandemic has thrown up unimaginable challenges for healthcare workers. Even simple outpatient procedures such as endoscopies can expose staff to the risk of infection.
Today, the U.S. Food and Drug Administration announced a final rule for the unique device identification system that, once implemented, will provide a consistent way to identify medical devices.
Biochemists at the University of California San Diego have uncovered patterns in the outer protein coat of group A Streptococcus that could finally lead to a vaccine against this highly infectious bacteria-responsible for more than 500,000 deaths a year, including toxic shock syndrome and necrotizing fasciitis or "flesh-eating disease."
At the heart of brain diseases such as amyotrophic lateral sclerosis, Alzheimer's disease, and Parkinson's disease is protein misfolding, in which distorted proteins are unable to perform their normal functions. At present, there is no known way to reverse protein misfolding.
› Verified 8 days ago
| Entity Name | Afc Physicians Of Connecticut, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003152984 PECOS PAC ID: 5193966893 Enrollment ID: O20130723000274 |
News Archive
Sorrento Therapeutics, Inc. and IGDRASOL announced today that IGDRASOL will be presenting updates of its analysis of proprietary late clinical stage NBN-Pac formulations, namely IG-001 (Cynviloq) and IG-004 (a D-a-tocopheryl polyethylene glycol succinate (TPGS)-based paclitaxel formulation) at the annual Nanomedicine 2013 meeting in Barcelona, Spain (April 11th - 12th).
The COVID-19 pandemic has thrown up unimaginable challenges for healthcare workers. Even simple outpatient procedures such as endoscopies can expose staff to the risk of infection.
Today, the U.S. Food and Drug Administration announced a final rule for the unique device identification system that, once implemented, will provide a consistent way to identify medical devices.
Biochemists at the University of California San Diego have uncovered patterns in the outer protein coat of group A Streptococcus that could finally lead to a vaccine against this highly infectious bacteria-responsible for more than 500,000 deaths a year, including toxic shock syndrome and necrotizing fasciitis or "flesh-eating disease."
At the heart of brain diseases such as amyotrophic lateral sclerosis, Alzheimer's disease, and Parkinson's disease is protein misfolding, in which distorted proteins are unable to perform their normal functions. At present, there is no known way to reverse protein misfolding.
› Verified 8 days ago
| Entity Name | Hartford Healthcare Urgent Care Centers Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093239683 PECOS PAC ID: 7618242777 Enrollment ID: O20170929001464 |
News Archive
Sorrento Therapeutics, Inc. and IGDRASOL announced today that IGDRASOL will be presenting updates of its analysis of proprietary late clinical stage NBN-Pac formulations, namely IG-001 (Cynviloq) and IG-004 (a D-a-tocopheryl polyethylene glycol succinate (TPGS)-based paclitaxel formulation) at the annual Nanomedicine 2013 meeting in Barcelona, Spain (April 11th - 12th).
The COVID-19 pandemic has thrown up unimaginable challenges for healthcare workers. Even simple outpatient procedures such as endoscopies can expose staff to the risk of infection.
Today, the U.S. Food and Drug Administration announced a final rule for the unique device identification system that, once implemented, will provide a consistent way to identify medical devices.
Biochemists at the University of California San Diego have uncovered patterns in the outer protein coat of group A Streptococcus that could finally lead to a vaccine against this highly infectious bacteria-responsible for more than 500,000 deaths a year, including toxic shock syndrome and necrotizing fasciitis or "flesh-eating disease."
At the heart of brain diseases such as amyotrophic lateral sclerosis, Alzheimer's disease, and Parkinson's disease is protein misfolding, in which distorted proteins are unable to perform their normal functions. At present, there is no known way to reverse protein misfolding.
› Verified 8 days ago
| Entity Name | Hartford Healthcare Medical Group Specialists Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023584216 PECOS PAC ID: 3173866241 Enrollment ID: O20190514001441 |
News Archive
Sorrento Therapeutics, Inc. and IGDRASOL announced today that IGDRASOL will be presenting updates of its analysis of proprietary late clinical stage NBN-Pac formulations, namely IG-001 (Cynviloq) and IG-004 (a D-a-tocopheryl polyethylene glycol succinate (TPGS)-based paclitaxel formulation) at the annual Nanomedicine 2013 meeting in Barcelona, Spain (April 11th - 12th).
The COVID-19 pandemic has thrown up unimaginable challenges for healthcare workers. Even simple outpatient procedures such as endoscopies can expose staff to the risk of infection.
Today, the U.S. Food and Drug Administration announced a final rule for the unique device identification system that, once implemented, will provide a consistent way to identify medical devices.
Biochemists at the University of California San Diego have uncovered patterns in the outer protein coat of group A Streptococcus that could finally lead to a vaccine against this highly infectious bacteria-responsible for more than 500,000 deaths a year, including toxic shock syndrome and necrotizing fasciitis or "flesh-eating disease."
At the heart of brain diseases such as amyotrophic lateral sclerosis, Alzheimer's disease, and Parkinson's disease is protein misfolding, in which distorted proteins are unable to perform their normal functions. At present, there is no known way to reverse protein misfolding.
› Verified 8 days ago
| Entity Name | Sound Physicians Of Massachusetts Ii Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1306376397 PECOS PAC ID: 9436421567 Enrollment ID: O20220607002184 |
News Archive
Sorrento Therapeutics, Inc. and IGDRASOL announced today that IGDRASOL will be presenting updates of its analysis of proprietary late clinical stage NBN-Pac formulations, namely IG-001 (Cynviloq) and IG-004 (a D-a-tocopheryl polyethylene glycol succinate (TPGS)-based paclitaxel formulation) at the annual Nanomedicine 2013 meeting in Barcelona, Spain (April 11th - 12th).
The COVID-19 pandemic has thrown up unimaginable challenges for healthcare workers. Even simple outpatient procedures such as endoscopies can expose staff to the risk of infection.
Today, the U.S. Food and Drug Administration announced a final rule for the unique device identification system that, once implemented, will provide a consistent way to identify medical devices.
Biochemists at the University of California San Diego have uncovered patterns in the outer protein coat of group A Streptococcus that could finally lead to a vaccine against this highly infectious bacteria-responsible for more than 500,000 deaths a year, including toxic shock syndrome and necrotizing fasciitis or "flesh-eating disease."
At the heart of brain diseases such as amyotrophic lateral sclerosis, Alzheimer's disease, and Parkinson's disease is protein misfolding, in which distorted proteins are unable to perform their normal functions. At present, there is no known way to reverse protein misfolding.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Todd A Bickmore, MD 1290 Silas Deane Hwy, Hartford Healthcare-cvo, Wethersfield, CT 06109-4337 Ph: () - | Dr Todd A Bickmore, MD 385 W Main St, Avon, CT 06001-4357 Ph: (860) 777-1280 |
News Archive
Sorrento Therapeutics, Inc. and IGDRASOL announced today that IGDRASOL will be presenting updates of its analysis of proprietary late clinical stage NBN-Pac formulations, namely IG-001 (Cynviloq) and IG-004 (a D-a-tocopheryl polyethylene glycol succinate (TPGS)-based paclitaxel formulation) at the annual Nanomedicine 2013 meeting in Barcelona, Spain (April 11th - 12th).
The COVID-19 pandemic has thrown up unimaginable challenges for healthcare workers. Even simple outpatient procedures such as endoscopies can expose staff to the risk of infection.
Today, the U.S. Food and Drug Administration announced a final rule for the unique device identification system that, once implemented, will provide a consistent way to identify medical devices.
Biochemists at the University of California San Diego have uncovered patterns in the outer protein coat of group A Streptococcus that could finally lead to a vaccine against this highly infectious bacteria-responsible for more than 500,000 deaths a year, including toxic shock syndrome and necrotizing fasciitis or "flesh-eating disease."
At the heart of brain diseases such as amyotrophic lateral sclerosis, Alzheimer's disease, and Parkinson's disease is protein misfolding, in which distorted proteins are unable to perform their normal functions. At present, there is no known way to reverse protein misfolding.
› Verified 8 days ago
Dr. Robert A Rothenberg, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 21 Arts Center Court, Avon, CT 06001 Phone: 860-674-9686 Fax: 860-674-9954 | |
Dr. Spencer G Erman, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 339 W Main St, Hartford Medical Group, Avon, CT 06001 Phone: 860-696-2150 Fax: 860-696-2160 | |
Alina Ileana Dobrita, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 46 W Avon Rd, Ste 301, Avon, CT 06001 Phone: 860-404-2905 Fax: 860-470-3198 | |
Dr. Marcin Jaremko, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 339 W Main St, Avon, CT 06001 Phone: 860-696-2150 Fax: 860-695-2160 | |
Dr. Anthony Roselli, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 54 W Avon Rd, Suite 101, Avon, CT 06001 Phone: 860-673-4534 Fax: 860-675-8798 | |
Richard Salmon, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 5 Hawks Rdg, Avon, CT 06001 Phone: 860-810-5468 | |
Eric Walsh Jr., M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 385 W Main St, Avon, CT 06001 Phone: 860-777-1280 |